跳至主要内容
临床试验/CTRI/2019/01/016826
CTRI/2019/01/016826尚未招募未知

TO COMPARE THE OUTCOME AND TOXICITY OF CONCOMITANT CHEMORADIOTHERAPYVsCONCOMITANT CHEMORADIOTHERAPY FOLLOWED BY INTRALUMINAL BRACHYTHERAPY IN MIDDLE ONE-THIRD OF CARCINOMA ESOPHAGUS

IGMC Shimla0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.All histologically proven cases of middle one â?? third of esophageal carcinoma
  • 2.Previously untreated.
  • 3.Lesions not more than 10 cm on barium swallow and endoscopy.
  • 4.Karnofsky Performance status (KPS) of more than 60%.
  • 5.Age of the patients should be 30-70yrs.

排除标准

  • 1.Patient not willing to give consent
  • 2.Patient who has already received radiotherapy
  • 3.Patients with distant metastasis.
  • 4.Age >70 years & <30years
  • 5.Deranged KFT (BUN or serum creatinine 2 times above the normal)
  • 6.Deranged LFT (Bilirubin 2 times above the normal limit)

研究者

发起方
IGMC Shimla

相似试验